Terry Ferguson
Chief Medical Officer Cadrenal Therapeutics
Terry Ferguson is a distinguished medical expert with over 25 years of leadership in the cardiovascular field and deep expertise in clinical development. Dr. Ferguson joined Cadrenal in February 2025 from Matinas BioPharma where he served as Chief Medical Officer. Previously, Dr. Ferguson served as Head of U.S. Cardiovascular Medical Affairs at Amgen and held several senior positions at AstraZeneca, including Vice President of US Cardiovascular Medical and Scientific External Relations, Therapeutic Area Vice President of Cardiovascular Global Medical Affairs, US Development brand leader for BRILINTA, and Senior Director, Clinical Research. Before joining AstraZeneca, he was Vice President of Surgical and Critical Care for The Medicines Company. Prior to joining industry in 2008, he had more than 20 years of academic experience as the Associate Director of Clinical Cardiology Research at the Texas Heart Institute, Co-Director of the Cardiology Fellowship Training Program at St. Luke’s Episcopal Hospital in Houston, where he was an Associate Professor of Medicine at Baylor College of Medicine, and a Clinical Assistant Professor at the University of Texas Health Science Center at Houston.
Seminars
As medicine becomes increasingly complex through the rise of precision and personalized approaches including increasing regulatory and compliance scrutiny, therole of Medical Affairs is more vital than ever. Yet defining and communicating its truevalue remains a challenge. Beyond publication counts or engagement numbers, thereal impact lies in enabling informed decision-making, driving scientific exchange, and improving patient outcomes.
This interactive workshop will help participants redefine what “value” means today, aligning Medical Affairs strategy with the needs of internal stakeholders, HCPs, payers, and patients, and demonstrating how the function leads in shaping evidence and education.
This workshop will explore:
- Redefining Impact in a Complex Landscape: Understand how Medical Affairs adds value in an era of scientific complexity
- Communicating Value Across Stakeholders: Map impact narratives that resonate with internal teams, HCPs, payers, and patients, demonstrating both efficiency and purpose
- The Emerging Role of Medical Affairs to Change Practice and Informing Patient Behaviours: Explore how Medical Affairs teams can shape clinical decision-making and drive better patient outcomes
